glp-1 and glp-2 drugs are all approved for glucose control in type 2 diabetes (T2D). Some of them also have additional indications reflecting their demonstrated benefits for cardiovascular disease, kidney health, obesity. None GLP-1 medications linked to major
Description
Glucagon-Like Peptide-1 Receptor Agonist Semaglutide Improves Eating Behavior and Glycemic Control in Japanese Obese Type 2 Diabetic Patients
The price is expected to collapse from CNY 2,0004,000 per month down to CNY 150350 within five years of generic entry
The biorepository targets the collection of milk samples and self-related health information for mother and infant dyad via a questionnaire
G., Pozzi, A., Zent, R
The GRADE approach assessed the quality of the evidence for each outcome across five domains: risk of bias, inconsistency, indirectness, imprecision and publication bias
1971;125:50P51P
